There is no shortage of investors who are bullish on Windtree Therapeutics Inc (WINT) stock

A share price of Windtree Therapeutics Inc [WINT] is currently trading at $0.44, up 14.78%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The WINT shares have gain 2.67% over the last week, with a monthly amount glided 16.94%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Windtree Therapeutics Inc [NASDAQ: WINT] stock has seen the most recent analyst activity on June 26, 2020, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $12.25.

Windtree Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.28 and $18.48. Windtree Therapeutics Inc [NASDAQ: WINT] shares were valued at $0.44 at the most recent close of the market.

Analyzing the WINT fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -2.8 and Total Capital is -0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3688 points at the first support level, and at 0.3027 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4921, and for the 2nd resistance point, it is at 0.5493.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Windtree Therapeutics Inc [NASDAQ:WINT] is 2.40. Further, the Quick Ratio stands at 2.40, while the Cash Ratio is 1.99.

Transactions by insiders

Recent insider trading involved Fraser Craig, President and CEO, that happened on Sep 27 ’23 when 2500.0 shares were purchased. President and CEO, Fraser Craig completed a deal on Sep 26 ’23 to buy 2500.0 shares. Meanwhile, President and CEO Fraser Craig bought 1497.0 shares on Apr 26 ’23.

Related Posts